Introduction and Objective: Chlorhexidine is used as an oral mouthwash to reduce oral colonization related to dental disease. Triphala (An ayurvedic preparation from the dried fruits of Emblica officinalis, Terminalia bellirica and Terminalia chebula) and Mimusops elengi(Munamal) are used as mouthwashes in Ayurvedic medicine and are known to have antimicrobial activity.
Introduction
Candida species, Pseudomonas species, Staphylococcus aureus and Escherichia coli are common microorganisms associated with serious superficial and systemic infections in man.
1,2 S. aureus is a major pathogen that causes a diverse range of infectious diseases.
2 P. aeruginosa is most commonly associated with chronic wound infections, ear infections and lung infections in patients with cystic fibrosis. 3 These three pathogens cause community as well as hospital acquired infections while the ability of Pseudomonas spp. to form biofilms contribute to their success as a pathogen. 4, 5, 6 MRSA is a major cause of nosocomial infections. 7 Available data show that MRSA accounts on average 57% of S. aureus isolates causing nosocomial infection in intensive care units (ICUs). 7 Fungal species, mainly yeasts and Aspergillus species, are commonly associated with patients with diabetes mellitus. 8 C. albicans accounts for > 90% of oral and systemic candida infections followed by C. tropicalis, C. parapsilosis, C. glabrata and C. krusei. 9, 10 Ayurvedic rasayana consisting of Amulaki/Nelli (Emblica officinalis), Bibhitaki/Bulu(Terminalia bellirica) and Halituki/Aralu (Terminalia chebula) commonly known as "Triphala" is effectively used in Ayurveda. 11, 12 Mimusops elengi(Munamal) 13 is a plant known to have antimicrobial activity which is also used in ayurvedic medicine. In our study we investigated the effect of these ayurvedic preparations Triphala and Munamal and chlorhexidine on planktonic microorganisms in -vitro.
Methods

Test strains and culture conditions
Five Candida type strains, (C. albicans: ATCC10231; C. tropicalis: ATCC13803; C. parapsilosis: ATCC22019; C. glabrata: ATCC90030: C. dubliniensis: MYA 580), three Gram positive cocci (S. aureus: ATCC25923; S. epidermidis: ATCC14990; MRSA: a clinical isolate), and two Gram negative bacilli (E. coli: ATCC25922; P. aeruginosa: ATCC27853) were used for this study. Stock cultures of Candida species were maintained on Sabouraud Dextrose Agar (SDA, Sigma-Aldrich, USA) slants and were subcultured onto SDA plates and incubated at 35  C for 24 hours. Other stock cultures were maintained on nutrient agar (NA)(Sigma-Aldrich, USA) slants and were subcultured onto NA plates and incubated at 35  C for 24 hours in order to obtain 24 hours fresh culture isolates. Preparation of Triphala: The dried plant materials were washed with running tap water and air dried for 48 hours. Each dried fruit (20.0 g) was measured. The mixture of three dried fruits was boiled by addition of 6 cups (1440 ml) of distilled water, until the final volume of the extract was 240 ml, following the standard Ayurvedic protocol.
Preparation of Mimusops elengi extract: Dried Mimusops elengi bark (60.0 g) was used to prepare the aqueous extract using the same protocol. An aliquot of prepared herbal aqueous extracts was freeze dried to determine the concentrations of working solutions.
14 The prepared decoctions were filtered and stored at 4  C up to two weeks until use. Chlorhexidine gluconate (Sigma Aldrich, USA) (0.2%) was used as a control.
Determination of the effect on planktonic cells
Inhibitory activity of 0.2% Chlorhexidine gluconate and the two herbal plant extracts (Triphala and Mimusops elengi extract) on planktonic test organisms were determined using an agar well diffusion method as described by Magaldi, with few modifications. 15 Standard suspensions (0.5 MacFarland) of test organisms were prepared in sterile normal saline and inoculated on Mueller-Hinton agar (MHA) separately to obtain a confluent growth. Five wells of 6 mm diameter each were prepared in each agar plate and the bottoms of the prepared wells sealed with 50 µl of sterile MHA. 200 µl of working solutions of 0.2% chlorhexidine gluconate, aqueous extracts of Triphala and Mimusops elengi were added into the wells separately with sterile distilled water as a negative control. 1.25 mg/ml Fluconazole (SigmaAldrich, USA) was used as positive control for Candida. 30 mg/l gentamicin solution was used as positive control for Gram negative test organisms and 30 mg/l vancomycin for Gram positive cocci tested. The diameter of the zone of inhibition was measured after overnight incubation of the agar plates at 37  C.
Minimum inhibitory concentration (MIC)
Minimum inhibitory concentration (MIC) of Candida was determined using the CLSI M-27A broth microdilution method with alamar blue modification. Suspensions of C. albicans and C. tropicalis (1×10 6 cells/ml) were prepared in sterile RPMI 1640 using 48-hour fresh Candida cultures. The final concentration of Triphala extract was 65 mg/ml and Mimusops elengi extract12 mg/ml. Serial two-fold dilutions (1/2, 1/4, 1/8, 1/16, 1/32 and 1/64) of antifungal agents were prepared using sterile distilled water. Prepared Candida suspensions (100 µl) were inoculated in triplicate to a sterile 96 well polystyrene microtiter plate and 100 µl of each dilution of antifungal agent was added to each well. A 100 µl of 0.02% Alamar blue stain was added to each well as an indicator. Plates were covered with a lid and sealed with parafilm and MIC was read after incubating the plate at 37  C for 48 hours. Any zone of inhibition (ZOI) in the agar well diffusion assay was considered as evidence of activity of the relevant ayurvedic preparation against each test organism. All tests were performed in triplicate.
Results
Activity of chlorhexidine gluconate and two ayurvedic preparations
The results of activity of working solutions of 0.2% Chlorhexidine gluconate, Triphala and Mimusops elengi aqueous extracts against test organisms are presented in Table 1 
MIC of the 3 test products against planktonic C. albicans and C. tropicalis
As shown in Table 2 , Chlorhexidine gluconate exhibited a MIC of 0.004 mg/ml for both planktonic Candida species. The MIC of Triphala for both Candida species was 32.5 mg/ml. Mimusops elengi extracts did not exhibit any activity against these 2 species of candida. 
Discussion
Chlorhexidine gluconate (0.2%), is a recommended, commercially available mouth rinse with reported activity against oral bacteria. 16 In the present study also it showed an activity against free living planktonic cells which indicated its effectiveness in preventing microbial colonization and viability. However long term use of this antiseptic as an oral rinse has side effects, including staining of teeth, alteration of taste sensation and development of antimicrobial resistance. 17 The use of alternative herbal extracts may help overcome these side effects. Mimusops elengi is known to have antimicrobial activity. 13 It is also used for treating or controlling oral complications such as dental caries and gum bleeding. However, according to the present study this extract had no inhibitory effect against Candida or other bacterial species except S. aureus and MRSA.
Triphala is a common ayurvedic preparation used for a broad range of oral and non-oral infections. It is reported to have anti-inflammatory, antioxidant, and antimicrobial activity against a wide spectrum of microorganisms including bacteria, yeasts and dermatophytes. 18, 19, 11 The active phytochemicals contributing to antimicrobial activity are tannic acid, chebulic acid, and flavonoids. Its antimicrobial activity against C. albicans and dermatophytes have been reported using the agar well diffusion assay. 18 In this in-vitro study Triphala was found to show activity against C. albicans, C. tropicalis, C. parapsilosis, S. aureus, MRSA, S. epidermidis, and P. aeruginosa planktonic cells. Antibiofilm activity of Triphala has been reported which suggests its usefulness as a general antiseptic with low side effects. Triphala has been shown to be effective in reducing biofilms of both C. albicans and Enterococcus faecalis in one study. 12 The MIC of Triphala for C. albicans and C. tropicalis was found to be 32.5 mg/ml in the current study. Further investigations are needed to determine the MIC of Triphala against the other Candida species. The current study demonstrates the antibacterial and anti-candida activity of Triphala. However, the role of Triphala against a wider spectrum of microorganisms, including oral colonizers would be useful in determining whether this ayurvedic product could be effectively used as an herbal mouth rinse to prevent oral pathogens including Candida species.
A limitation of this study is that only the aqueous extract of both Triphala and Mimusops elengi were tested for antimicrobial activity. It would be useful to test the ethanolic extracts of both and compare the antimicrobial activity of aqueous and ethanolic extracts.
Conclusion
The findings of this study further strengthen the effectiveness of 0.2% chlorhexidine gluconate as an antimicrobial agent. Triphala is a potential antimicrobial agent against C. albicans, C. tropicalis, C. parapsilosis, S. aureus, S. epidermidis, MRSA and P. aeruginosa. S. aureus and MRSA are sensitive to Munamal extract.
